EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Evolutionary Predictors of Post-COVID Syndrome

Maria Luisa Asensio Tomás iD, Philip Erick Wikman-Jorgensen iD, Jose Antonio Quesada-Rico iD, José Miguel Seguí-Ripoll iD, Vicente Gil-Guillén iD, Vicente Giner-Galvañ iD

Journal of Clinical Medicine · 15.07.2026 · 15 (14) · 5550

DOI: 10.3390/jcm15145550 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 15.07.2026. Verfasst von Maria Luisa Asensio Tomás und 5 weiteren Autor:innen. Beteiligte Einrichtung: Internal Medicine Department, San Juan de Alicante University Clinical Hospital, 03550 San Juan de Alicante, Spain. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To analyze evolutionary predictors of post-COVID syndrome (PCS).

Methods

This Cohort study was conducted from April 2021 to December 2023. PCS persistence was defined as a score of ≥2 points on the post-COVID-19 Functional Status (PCFS) scale (range 0–4, where higher scores indicate more limitations). Symptom clusters were identified using correspondence analysis. The association between PCS persistence and symptoms and symptom clusters were assessed using multivariable analysis, considering both the acute infection period and the baseline PCS visit variables.

Results

The 112 included patients showed a mean of 6.1 symptoms (standard deviation [SD] 3.2), most commonly dyspnea (67.9%), asthenia (67.0%), fatigue (57.1%), and myalgia (49.1%). Regarding baseline functional status, 59.8% scored 2 points on the PCFS; 40.2%, 3 points; and 2.6%, 4 points. Moreover, 68.7% had depression and 83.0%, anxiety. Two symptom clusters emerged: anxiety + depression + severe PCFS, and palpitations + hyporexia + dyspnea. At a mean of 12.1 months (SD 9.2), the persistence rate was 33.9% (cumulative persistence time 20 months [SD 11.9]). Persistence was significantly associated with the absence of rhinitis (odds ratio [OR] 3.67, 95% confidence interval [CI] 1.28–10.52) during acute infection, and the presence of fatigue (OR 4.88, 95% CI 1.77–13.44) and depression (moderate: OR 4.28, 95% CI 1.05–17.44; severe: OR 10.31, 95% CI 2.60–40.90) at the baseline visit. The model multivariable demonstrated a good fit (likelihood ratio test 30.1, p < 0.001) and predictive capacity (area under the receiver operating curve 0.804). The anxiety + depression + severe PCFS cluster was significantly associated with persistence (OR 3.26, 95% CI 1.21–8.76; p = 0.012).

Conclusions

A third of patients with PCS still experience significant functional impairment 20 months after onset. Persistence is associated with the absence of rhinitis during acute infection and with severe anxiety, depression, and functional impairment measured by the PCFS on detection of PCS.

Schlagwörter

Stichwörter der Autor:innen

PCFSpersistent COVIDpost-COVID syndromesymptomatic association

Autor:innen und Institutionen

  • Internal Medicine Department, San Juan de Alicante University Clinical Hospital, 03550 San Juan de Alicante, Spain.
  • Fundación para el Fomento de la Investigación Sanitaria y Biomédica (FISABIO), 46020 Valencia, Spain.
  • Infectious Diseases Unit, San Carlos Clinical University Hospital, 28040 Madrid, Spain.
  • Department of Clinical Medicine, Miguel Hernández University of Elche, 03202 Elche, Spain.
  • Internal Medicine Department, Virgen de los Lirios University General Hospital, 03804 Alcoy, Spain.
  • Medicine Area, Department of Community Nursing, Preventive Medicine and Public Health and History of Science Health, University of Alicante, 03690 San Vicente del Raspeig, Spain.

ORCID-Profile: Maria Luisa Asensio Tomás, Philip Erick Wikman-Jorgensen, Jose Antonio Quesada-Rico, José Miguel Seguí-Ripoll, Vicente Gil-Guillén, Vicente Giner-Galvañ

Zitieren

APA

Tomás, M. L. A., Wikman-Jorgensen, P. E., Quesada-Rico, J. A., Seguí-Ripoll, J. M., Gil-Guillén, V., & Giner-Galvañ, V. (2026). Evolutionary Predictors of Post-COVID Syndrome. Journal of Clinical Medicine, 15(14), 5550. https://doi.org/10.3390/jcm15145550

Vancouver

Tomás MLA, Wikman-Jorgensen PE, Quesada-Rico JA, Seguí-Ripoll JM, Gil-Guillén V, Giner-Galvañ V. Evolutionary Predictors of Post-COVID Syndrome. Journal of Clinical Medicine. 2026;15(14):5550. doi:10.3390/jcm15145550

BibTeX
@article{Toms2026,
  author = {Tomás, Maria Luisa Asensio and Wikman-Jorgensen, Philip Erick and Quesada-Rico, Jose Antonio and Seguí-Ripoll, José Miguel and Gil-Guillén, Vicente and Giner-Galvañ, Vicente},
  title = {Evolutionary Predictors of Post-COVID Syndrome},
  journal = {Journal of Clinical Medicine},
  year = {2026},
  volume = {15},
  number = {14},
  pages = {5550},
  doi = {10.3390/jcm15145550}
}
Kostenlos starten →